Soluble Immune Checkpoints in Intra-Abdominal Infections
Key facts
- Who runs it
- Istanbul Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 75 people enrolled
- Started
- 1 Dec 2023
- Ended
- 1 Aug 2025
- Type of study
- Observational, 3 groups
- Treatments tested
- Soluble Immune checkpoint levels
- Record updated
- 8 July 2026
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients with intraabdominal infections due to gastrointestinal pathologies
Who cannot take part
- Patients without intraabdominal infections
- Malignities
- Pregnancy
- Immune deficiency
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Intraabdominal infections is a life-threatening syndrome with a high incidence and a significant economic burden. The early-stage cytokine storm and the late-stage immunosuppression contribute to the mortality of sepsis. Immune checkpoints expressed on lymphocytes and antigen-presenting cells (APCs) play a crucial role in the pathogenesis of sepsis by regulating immune dysfunction. Specific therapies targeting immune checkpoints have shown great potential in animal and preclinical studies, paving the way for further clinical research. In this study, the significance of serum immune checkpoints - sCD25 (IL-2Ra), 4-1BB, B7.2 (CD86), Free Active TGF-beta1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, and Galectin-9 - will be investigated in patients with intraabdominal infection.
The 3 groups in the trial
- Severe Intraabdominal Infection
Severe Intraabdominal Infection patients with qSOFA 2 and 3
Treatment: Soluble Immune checkpoint levels
- Mild Intraabdominal Infection
Mild Intraabdominal Infection patients with qSOFA 0 and 1
Treatment: Soluble Immune checkpoint levels
- Control
Healthy Volunteers without intraabdominal infection
Treatment: Soluble Immune checkpoint levels
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Serum Soluble Immune Checkpoint Molecules in Intra-abdominal Infection: Association With Disease Severity and Mortality
- Record updated
- 8 July 2026